1. S. Clementi, G. Coata, C. Ebert, L. Lassiani, P. Linda, S. Hellberg, M. Sjoestroem, S. Wold, Partial least squares analysis in drug analysis, in: D. Hadzi, B. Jerman-Blazic (Eds.), QSAR in Drug Design and Toxicology, Elsevier, Amsterdam, 1987, pp. 19–23.
2. I.M. Asher, C. Zervos (Eds.), Structural correlates of carcinogenesis and mutagenesis, a guide to testing priorities, Proceedings of the Second FDA Office Science Summer Symposium, US Naval Academy, Aug. 31–Sept. 2, 1977.
3. Composition activity relationships—CARE: Part I. Exploratory multivariate analysis of elements, polycyclic aromatic hydrocarbons and mutagenicity in air samples;Vogt;Chemometrics Intelligent Laboratory Systems,1989
4. Quantitative structure–activity relationships study of antiarrhythmic phenylpridines using multivariate partial least squares modeling;Hasegawa;Chemometrics Intelligent Laboratory Systems,1992
5. Chance factors in studies of quantitative structure–activity relationships;Topliss;Journal of Medicinal Chemistry,1979